United States · Investor

KdT Ventures

Last cheque observed Jun 2026; 50 cheques on record.

Deploying nowNew fund $3.5M, Jun 2024VC firm

SeedSeries AFrontier ScienceChemistryBiology

Deploying now
53%of best year8cheques in 12 months, 50 on record
Since the last cheque152days00hrs00min00sec
Median round$12MRounds led1 of 50Sole investor4 roundsMostly inUnited States, 95%
Pitch KdT Ventures

KdT Ventures highlights

  1. 01

    8 cheques in the last 12 months

  2. 02

    Mostly Series A and Seed: 51% of its rounds

  3. 03

    Sole investor in 4 rounds, median $2.9M

What they do

KdT is an early-stage frontier science firm. We back founders rewriting the physical layer of the world, from pre-seed through Series A.From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries A
Sectors
Frontier ScienceChemistryBiology
Based in
Austin, United States
Cold pitches
Not accepted

The record

Every round we can evidence, newest first50 appearances

  1. 2026

    6 rounds

  2. Jun
    Rejuvenate BioVenture · US$6.0MWith 2 others
  3. Jun
    Montara TherapeuticsGrant · US$1.0MSole investor
  4. Mar
    Tacit TherapeuticsSeries A · US$19MWith 2 others
  5. Mar
    AzitraUS$31MWith 3 others
  6. Mar
    MacroCycle TechnologiesSeed · US$3.0MWith 5 others
  7. Jan
    General SenseVenture · USUndisclosedWith 2 others
  8. 2025

    14 rounds

  9. Nov
    SkeletalisSeed · US$8.0MWith 1 other
  10. Nov
    AzitraUS$1.5MWith 3 others
  11. Oct
    Zag BioSeries A · US · Firms' own news pages$80MWith 9 others
  12. Oct
    Faeth TherapeuticsSeries A · US$25MWith 4 others
  13. Aug
    DebutVenture · US$20MWith 3 others
  14. Jul
    Character BiosciencesSeries B · US · Jefferson Life Sciences$93MWith 7 others
  15. May
    Montara TherapeuticsGrant · US$3.3MSole investor
  16. May
    ZymochemVenture · USUndisclosedWith 3 others
  17. Apr
    March BiosciencesGrant · US$200KWith 2 others
  18. Apr
    PHNX MaterialsSeed · US$2.5MSole investor
  19. Feb
    RarebirdVenture · US$1.0MWith 5 others
  20. Feb
    Reverb TherapeuticsSeed · CA · Firms' own news pages$12MWith 5 others
  21. Feb
    MacroCycleSeed · US$6.5MWith 4 others
  22. Feb
    Dimension InxGrant · US$75KWith 2 others
  23. 2024

    10 rounds

  24. Oct
    March BiosciencesSeries A · US · 4BIO Capital$28MWith 10 others
  25. Oct
    Onc.AIGrant · US$2.0MWith 2 others
  26. Oct
    Terray TherapeuticsSeries B · US$120MWith 4 others
  27. Jul
    Rejuvenate BioGrant · US$4.0MWith 1 other
  28. May
    Radar TherapeuticsSeed · US$13MWith 4 others
  29. May
    ElegenSeries B · US$35MWith 2 others
  30. Apr
    Greeneye TechnologyVenture · IL$20MWith 3 others
  31. Mar
    Tierra BiosciencesSeries A · US$11MWith 2 others
  32. Feb
    EquiiSeed · US$200KWith 2 others
  33. Jan
    Motif NeurotechSeries A · US$19MWith 1 other
  34. 2023

    8 rounds

  35. Nov
    Aperiam BioSeed · US$9.0MSole investor
  36. Nov
    Cypris MaterialsVenture · US$3.2MWith 2 others
  37. Jul
    SURGE TherapeuticsSeries B · US$32MWith 4 others
  38. Jul
    TransceraVenture · USUndisclosedWith 4 others
  39. Jul
    CanaeryVentureUndisclosedWith 2 others
  40. Mar
    AndesSeries A · US$15MWith 2 others
  41. Mar
    Unravel BiosciencesGrant · US$550KWith 1 other
  42. Feb
    CheckerspotSeries C · US$55MWith 3 others
  43. 2022

    2 rounds

  44. Oct
    Tavros TherapeuticsVenture · US$18MWith 1 other
  45. Apr
    TheatorSeries A · US$24MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration2 named

ACAndrew Cain McClaryInitial Limited Partner and President of the General PartneriFiling they signed
MHMack HealyManaging MemberiFiling they signed

We also hold 10 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$285Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
KDT Ventures LLC
SEC number
CRD 319012

Who backs their funds

1 LP on record in KdT Ventures's funds

Funds
1

The institutions that put money into its funds, which the firm then invests in companies.Source: an LP list.

What they claim to have backed

From their own portfolio page (on their website)

5 of 54 we have independently watched raise

Abridge Digital HealthAzitra Therapeutics IElo Life SystemsHi Fidelity GeneticsPathAI Digital HealthAndes Industrials SAperiam Bio LifeBraid Health DigitalBullseye Bio TherapeuticsCharacter Bio TherapeuticsCirsium Biosciences LifeCreasallis Therapeutics SCypris Industrials ADebut Biotechnology IndustrialsDimension Bio MedTechElegen Life SciencesElemental Machines FrontierEpana Bio TherapeuticsEquii Industrials AEvolved Therapeutics TherapeuticsExthymic Corporation LifeFaeth Therapeutics AGeneral Sense FrontierIndex Biosystems FrontierLeeta Materials IndustrialsMacroCycle Technologies IndustrialsMarchMarigold Health DigitalModulus Therapeutics TherapeuticsMolecule Frontier SMotif Neurotech MedTechNeptune Bio TherapeuticsNosis Bio TherapeuticsOncPHNX Materials IndustrialsPerceptive MedTech SRadar Therapeutics TherapeuticsRejuvenate Bio TherapeuticsRemedy Robotics MedTechRevel Frontier SSTRM.BIO Therapeutics SSedona Health DigitalSkeletalis Therapeutics SSolugen Industrials SSublime Nuclear IndustrialsSynteny Therapeutics STheator Digital HealthTierra Biosciences LifeTranscera Therapeutics STycho Pharma DigitalUnravel Biosciences TherapeuticsXilis Life SciencesZag Bio TherapeuticsZymoChem Industrials S

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as KdT Ventures. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies KdT Ventures put money into.

Mentioned on podcasts

Episodes that name KdT Ventures in their description, not their title.

Quick answers about KdT Ventures

What does KdT Ventures invest in?

KdT Ventures invests most often at Series A and Seed (51% of the rounds on record), in sectors such as Frontier Science, Chemistry and Biology.

How active is KdT Ventures?

50 investments on record, 8 of them in the last 12 months, and it led 1. The most recent was in Jun 2026.

What has KdT Ventures invested in recently?

Its most recent investments on record: Rejuvenate Bio (Venture, Jun 2026), Montara Therapeutics (Grant, Jun 2026) and Tacit Therapeutics (Series A, Mar 2026).

How big are KdT Ventures's cheques?

The median round it joins is $12M.

Does KdT Ventures lead rounds?

Sometimes: it led 1 of its 50 investments on record (2%).

Where does KdT Ventures invest?

Most of the companies it backs are in the United States (95%).

Is KdT Ventures investing now?

Yes: it is actively investing, with 8 investments in the last 12 months.

Who does KdT Ventures invest alongside?

Most often National Science Foundation (7 rounds together), Digitalis Ventures (6 rounds together) and Alexandria Venture Investments (4 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it